CTCs are cancer cells that have detached from a primary tumor and entered the bloodstream, potentially leading to metastasis. This minimally invasive “liquid biopsy” enables real-time cancer monitoring, prognosis evaluation, and treatment guidance.
Patients diagnosed with cancer: Monitor progression and treatment outcomes. High-risk individuals: Early detection in those with family history or genetic predispositions. Patients undergoing therapy: Assess responsiveness to current treatments. Post-treatment monitoring: Detects signs of recurrence in remission patients.
Blood
14 days
We help you revitalize your body’s natural energy and vitality through scientifically designed health management plans, enabling you to live a healthier and more confident life.
